These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15502250)

  • 1. Heart disease, clinical proteomics and mass spectrometry.
    Stanley BA; Gundry RL; Cotter RJ; Van Eyk JE
    Dis Markers; 2004; 20(3):167-78. PubMed ID: 15502250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in MALDI mass spectrometry in clinical diagnostic applications.
    Ng EW; Wong MY; Poon TC
    Top Curr Chem; 2014; 336():139-75. PubMed ID: 23563502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery.
    Silbiger VN; Luchessi AD; Hirata RD; Neto LG; Pastorelli CP; Ueda EK; dos Santos ES; Pereira MP; Ramos R; Sampaio MF; Armaganijan D; Paik SH; Murata Y; Ooi GT; Ferguson EW; Hirata MH
    Clin Chim Acta; 2011 May; 412(11-12):1086-93. PubMed ID: 21356205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics.
    Bouamrani A; Ternier J; Ratel D; Benabid AL; Issartel JP; Brambilla E; Berger F
    Clin Chem; 2006 Nov; 52(11):2103-6. PubMed ID: 16990423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELDI-TOF-MS proteomics of breast cancer.
    Clarke CH; Buckley JA; Fung ET
    Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of cardiac troponin I pull-down by IDM affinity beads and SELDI.
    Bovenkamp DE; Stanley BA; Van Eyk JE
    Methods Mol Biol; 2007; 357():91-102. PubMed ID: 17172682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course proteomic profile of rat acute myocardial infarction by SELDI-TOF MS analysis.
    Zhang G; Zhou B; Zheng Y; Feng K; Rao L; Zhang J; Xin J; Zhang B; Zhang L
    Int J Cardiol; 2009 Jan; 131(2):225-33. PubMed ID: 18180059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
    Ndao M
    Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
    Seibert V; Ebert MP; Buschmann T
    Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
    Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
    Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
    Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
    Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A path or a new road in laboratory diagnostics? Biological mass spectrometry: facts and perspectives.
    Elek G; Lapis K
    Pathol Oncol Res; 2006; 12(3):178-83. PubMed ID: 16998599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly imprinted polymers coupled to matrix assisted laser desorption ionization mass spectrometry for femtomoles detection of cardiac troponin I peptides.
    Cenci L; Anesi A; Busato M; Guella G; Bossi AM
    J Mol Recognit; 2016 Jan; 29(1):41-50. PubMed ID: 26373625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for purification and mass spectrometry identification of SELDI peaks corresponding to low-abundance plasma and serum proteins.
    Fertin M; Burdese J; Beseme O; Amouyel P; Bauters C; Pinet F
    J Proteomics; 2011 Apr; 74(4):420-30. PubMed ID: 21184852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mass spectrometry and clinical proteomics].
    Baudin B
    Ann Biol Clin (Paris); 2015; 73(1):39-48. PubMed ID: 25582721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.